ABL Bio Market Cap

ABL Bio has a market cap or net worth of 9.56 trillion as of November 26, 2025. Its market cap has increased by 431.22% in one year.

Market Cap

9.56T

Enterprise Value

9.47T

Revenue

88.44B

Ranking

n/a

PE Ratio

n/a

Stock Price

173,400.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 9.56T, an increase of 1,470.57%. That is a compound annual growth rate of 48.69%.

Market Cap History

Date	Market Cap	% Change
Nov 26, 2025	9.56T	562.13%
Dec 30, 2024	1.44T	22.53%
Dec 28, 2023	1.18T	7.19%
Dec 29, 2022	1.10T	5.54%
Dec 30, 2021	1.04T	-27.59%
Dec 30, 2020	1.44T	31.46%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 19, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	86.90T
Celltrion	41.00T
ALTEOGEN	28.93T
SK Biopharmaceuticals	9.91T
Yuhan	8.73T
Peptron	8.60T
LigaChem Biosciences	6.49T
HLB Co., Ltd.	5.91T

Market Cap Rankings